Researchers from Postnova Analytics, Landsberg, Germany, have developed a quantitative method to detect traces of toxic metals in tattoo ink using asymmetrical flow field-flow fractionation in combination with inductively coupled plasma mass spectrometry (AF4-ICP-MS).
Photo Credit: Mikhall_Kayl/Shutterstock.com
Researchers from Postnova Analytics, Landsberg, Germany, have developed a quantitative method to detect traces of toxic metals in tattoo ink using asymmetrical flow field-flow fractionation in combination with inductively coupled plasma mass spectrometry (AF4-ICP-MS) (1).
Tattoo popularity has risen sharply over the last decade and with it an increasing level of concern over the safety of tattoo inks. Currently, manufacturers of tattoo inks are under no obligation to reveal their constituents, despite the potential health risks associated with some ingredients. As most tattoo inks on the EU market are imported from the US (2), this is unlikely to change, which has increased the need for analytical methods to quantitatively assess possible allergenic ingredients in tattoo inks. “Tattoo ink is a very complex mixture of different kinds of ingredients,” said Florian Meier, Research and Development, Postnova. “Mostly not very well characterized,” he continued.
A recent report by the European Commission (EC) found a high level of variation in tattoo ink constituents, including a number of hazardous chemicals (2). The report found that 43% of tested inks contained polycyclic aromatic hydrocarbons (PAHs), 14% included primary aromatic amines (PAAs), 9% contained heavy metals, 6% included preservatives, and a further 11% had microbiological contamination (2).
Despite these findings there is an absence of comprehensive methods capable of characterizing tattoo ink ingredients for proper toxicological evaluation, and this knowledge gap was continually highlighted within the EC report (2).
Researchers at Postnova tackled one facet of this issue by developing a method using AF4-ICP-MS to detect traces of toxic metals in four ink samples of unknown origin. “AF4-MALS-ICP-MS allows for the fractionation and simultaneous sizing as well as elemental speciation of (nano)-particulate tattoo ink ingredients [pigments]. By these means, a correlation between ingredients of various sizes and their respective metal contents is possible,” explained Meier.
“AF4-ICP-MS enables quantification of various (nano)-metallic ingredients down to trace levels [< mg/L],” according to Meier, and allows the “comparison of AF4-ICP-MS with batch-ICP-MS data” to differentiate between dissolved and particulate metals, which can be used interpret toxicological findings.
This research is a positive step, however, more research and method development is still required to produce the analytical methods capable of fully monitoring and regulating the tattoo ink market. - L.B.
Reference
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.